The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia. / Toft, P; Nilsen, B U; Bollen, P; Lillevang, S; Olsen, K E; Brøchner, A C; Larsen, N H.

In: Acta Anaesthesiologica Scandinavica, Vol. 51, No. 6, 2007, p. 679-686.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Toft, P, Nilsen, BU, Bollen, P, Lillevang, S, Olsen, KE, Brøchner, AC & Larsen, NH 2007, 'The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia', Acta Anaesthesiologica Scandinavica, vol. 51, no. 6, pp. 679-686. https://doi.org/10.1111/j.1399-6576.2007.01312.x

APA

Toft, P., Nilsen, B. U., Bollen, P., Lillevang, S., Olsen, K. E., Brøchner, A. C., & Larsen, N. H. (2007). The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia. Acta Anaesthesiologica Scandinavica, 51(6), 679-686. https://doi.org/10.1111/j.1399-6576.2007.01312.x

Vancouver

Toft P, Nilsen BU, Bollen P, Lillevang S, Olsen KE, Brøchner AC et al. The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia. Acta Anaesthesiologica Scandinavica. 2007;51(6):679-686. https://doi.org/10.1111/j.1399-6576.2007.01312.x

Author

Toft, P ; Nilsen, B U ; Bollen, P ; Lillevang, S ; Olsen, K E ; Brøchner, A C ; Larsen, N H. / The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia. In: Acta Anaesthesiologica Scandinavica. 2007 ; Vol. 51, No. 6. pp. 679-686.

Bibtex

@article{69b24de69f834cd981b1f61428c18a34,
title = "The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia",
abstract = "BACKGROUND: Increased survival with high-volume continuous veno-venous haemofiltration (CVVH) has been demonstrated in critically ill patients. This may be the result of intensified blood purification or an effect on the immune system. We hypothesized that CVVH modifies the cell-mediated immunity. We investigated the effect of high-volume CVVH for 24 h on the cell-mediated immunity following endotoxin infusion.METHODS: Thirty pigs were divided into three groups. Ten pigs received 30 microg/kg of Escherichia coli endotoxin. These pigs were treated with CVVH (replacement 35 ml/kg/h) over the following 24 h. Ten pigs received the same bolus of endotoxin and ten pigs served as a control group. The adhesion molecules CD18, CD44 and CD62L and the ability to respond with an oxidative burst were measured. The number of neutrophils was counted in blood and lung tissue. The lymphoproliferative response and cytokines interleukin-6 and interleukin-10 were measured.RESULTS: The infusion of endotoxin was followed by initial granulocytopenia and, later, granulocytosis, activation of CD18 and CD62L, and increased oxidative burst. The cytokine level was increased. CVVH had no effect on the adhesion molecules or cytokine level and did not reduce the number of granulocytes in the lung significantly. CVVH, however, reduced the oxidative burst activity of neutrophils after 2 h of treatment.CONCLUSION: In the first few hours after endotoxaemia, high-volume CVVH reduced the oxidative burst activity of neutrophils. However, in the long term, CVVH was unable to modify the endotoxin-induced changes in cell-mediated immunity.",
keywords = "Animals, Disease Models, Animal, Electrocardiography, Endotoxemia/immunology, Hemofiltration, Immunity, Cellular, Neutrophils/physiology, Swine",
author = "P Toft and Nilsen, {B U} and P Bollen and S Lillevang and Olsen, {K E} and Br{\o}chner, {A C} and Larsen, {N H}",
year = "2007",
doi = "10.1111/j.1399-6576.2007.01312.x",
language = "English",
volume = "51",
pages = "679--686",
journal = "Acta Anaesthesiologica Scandinavica",
issn = "0001-5172",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia

AU - Toft, P

AU - Nilsen, B U

AU - Bollen, P

AU - Lillevang, S

AU - Olsen, K E

AU - Brøchner, A C

AU - Larsen, N H

PY - 2007

Y1 - 2007

N2 - BACKGROUND: Increased survival with high-volume continuous veno-venous haemofiltration (CVVH) has been demonstrated in critically ill patients. This may be the result of intensified blood purification or an effect on the immune system. We hypothesized that CVVH modifies the cell-mediated immunity. We investigated the effect of high-volume CVVH for 24 h on the cell-mediated immunity following endotoxin infusion.METHODS: Thirty pigs were divided into three groups. Ten pigs received 30 microg/kg of Escherichia coli endotoxin. These pigs were treated with CVVH (replacement 35 ml/kg/h) over the following 24 h. Ten pigs received the same bolus of endotoxin and ten pigs served as a control group. The adhesion molecules CD18, CD44 and CD62L and the ability to respond with an oxidative burst were measured. The number of neutrophils was counted in blood and lung tissue. The lymphoproliferative response and cytokines interleukin-6 and interleukin-10 were measured.RESULTS: The infusion of endotoxin was followed by initial granulocytopenia and, later, granulocytosis, activation of CD18 and CD62L, and increased oxidative burst. The cytokine level was increased. CVVH had no effect on the adhesion molecules or cytokine level and did not reduce the number of granulocytes in the lung significantly. CVVH, however, reduced the oxidative burst activity of neutrophils after 2 h of treatment.CONCLUSION: In the first few hours after endotoxaemia, high-volume CVVH reduced the oxidative burst activity of neutrophils. However, in the long term, CVVH was unable to modify the endotoxin-induced changes in cell-mediated immunity.

AB - BACKGROUND: Increased survival with high-volume continuous veno-venous haemofiltration (CVVH) has been demonstrated in critically ill patients. This may be the result of intensified blood purification or an effect on the immune system. We hypothesized that CVVH modifies the cell-mediated immunity. We investigated the effect of high-volume CVVH for 24 h on the cell-mediated immunity following endotoxin infusion.METHODS: Thirty pigs were divided into three groups. Ten pigs received 30 microg/kg of Escherichia coli endotoxin. These pigs were treated with CVVH (replacement 35 ml/kg/h) over the following 24 h. Ten pigs received the same bolus of endotoxin and ten pigs served as a control group. The adhesion molecules CD18, CD44 and CD62L and the ability to respond with an oxidative burst were measured. The number of neutrophils was counted in blood and lung tissue. The lymphoproliferative response and cytokines interleukin-6 and interleukin-10 were measured.RESULTS: The infusion of endotoxin was followed by initial granulocytopenia and, later, granulocytosis, activation of CD18 and CD62L, and increased oxidative burst. The cytokine level was increased. CVVH had no effect on the adhesion molecules or cytokine level and did not reduce the number of granulocytes in the lung significantly. CVVH, however, reduced the oxidative burst activity of neutrophils after 2 h of treatment.CONCLUSION: In the first few hours after endotoxaemia, high-volume CVVH reduced the oxidative burst activity of neutrophils. However, in the long term, CVVH was unable to modify the endotoxin-induced changes in cell-mediated immunity.

KW - Animals

KW - Disease Models, Animal

KW - Electrocardiography

KW - Endotoxemia/immunology

KW - Hemofiltration

KW - Immunity, Cellular

KW - Neutrophils/physiology

KW - Swine

U2 - 10.1111/j.1399-6576.2007.01312.x

DO - 10.1111/j.1399-6576.2007.01312.x

M3 - Journal article

C2 - 17567268

VL - 51

SP - 679

EP - 686

JO - Acta Anaesthesiologica Scandinavica

JF - Acta Anaesthesiologica Scandinavica

SN - 0001-5172

IS - 6

ER -

ID: 324128464